Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
about
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)Edible solid lipid nanoparticles (SLN) as carrier system for antioxidants of different lipophilicityImportance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives.Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery.Solid lipid nanoparticle-based calix[n]arenes and calix-resorcinarenes as building blocks: synthesis, formulation and characterization.Potential bioavailability enhancement of bioactive compounds using food-grade engineered nanomaterials: a review of the existing evidence.Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations.Solid lipid microparticles as an approach to drug delivery.A perspective overview on lipospheres as lipid carrier systems.Solid lipid nanoparticles as oral delivery systems of phenolic compounds: Overcoming pharmacokinetic limitations for nutraceutical applications.Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery.Solid lipid nanoparticles (SLNs) derived from para-acyl-calix[9]-arene: preparation and stability.Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.Production and optimization of valproic acid nanostructured lipid carriers by the Taguchi design.Stability of plant virus-based nanocarriers in gastrointestinal fluids.Technical tip: high-resolution isolation of nanoparticle-protein corona complexes from physiological fluids.Squalene-containing nanostructured lipid carriers promote percutaneous absorption and hair follicle targeting of diphencyprone for treating alopecia areata.Testosterone solid lipid microparticles for transdermal drug delivery. Formulation and physicochemical characterization.Preparation of nanoliposome loaded with peanut peptide fraction: stability and bioavailability.Poly(PEGDMA-MAA) copolymeric micro and nanoparticles for oral insulin deliveryNovel Caffeic Acid Nanocarrier: Production, Characterization, and Release Modeling
P2860
Q34444568-F0B8396F-8D01-4A52-86FF-24C3E7DF482EQ36278649-03651B99-1A4B-418B-BCAC-FBD460C097B9Q37004099-F076EBFA-341A-4158-88DC-8B96B6183DE9Q37996097-AD5C84D6-7D5D-4DB8-B995-881465EE7169Q38160303-DEC6B78D-716D-4A6D-97AA-A223FB771143Q38206137-E28EC1E6-36F8-4A1E-B878-C83380AB4D92Q38207151-9473558B-91E9-4D0B-8027-C2B371AEDEDBQ38267752-15F40F77-EAA2-4317-9AB6-473A48A4391EQ38271617-0142EE79-CB30-4586-BC3B-FAB46D5696D7Q38550745-7C4A5637-B17F-4F43-8801-054AEC56C1C0Q39518383-8AF1A32D-E7B8-484B-962F-CC6448D72CB9Q42869520-7D5ED241-9BA8-42E3-A1CF-DB276FEDCB8DQ43263297-47B1D0A0-C058-40A8-AA2C-90EEEEBB4E38Q45954910-B5C2889D-8330-4694-B732-1C4E536ABC9BQ47258248-E328414E-928D-4B79-AA3C-9F719C75D9E3Q48664150-E354A387-C6EC-451E-A494-2C3F7BB35FF9Q50501851-E3D97A93-F8B5-4659-A5C7-F4A1B1FBE06CQ50975740-B11430F9-5662-40D1-8838-EF3B07B9720EQ53139524-81F666E9-FC69-44B6-AB6C-EF34ACE41174Q57342830-48D5C410-B2DC-4733-B907-7005D2FFEFEBQ59018330-5E5EC494-3462-4E1B-B814-9B27E3B853FB
P2860
Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dispersions in artificial gastrointestinal media.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@ast
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@en
type
label
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@ast
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@en
prefLabel
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@ast
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@en
P1476
Electrolyte- and pH-stabilitie ...... ficial gastrointestinal media.
@en
P2093
Zimmermann E
P304
P356
10.1016/S0939-6411(01)00167-9
P407
P577
2001-09-01T00:00:00Z